|Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease|
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
|Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research|
AIR Maas, DK Menon, PD Adelson, N Andelic, MJ Bell, A Belli, P Bragge, ...
The Lancet Neurology 16 (12), 987-1048, 2017
|Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis|
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
|High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial|
PS Aisen, LS Schneider, M Sano, R Diaz-Arrastia, CH Van Dyck, ...
Jama 300 (15), 1774-1783, 2008
|Diagnosis, prognosis, and clinical management of mild traumatic brain injury|
HS Levin, RR Diaz-Arrastia
The Lancet Neurology 14 (5), 506-517, 2015
|Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes|
G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ...
Archives of neurology 67 (12), 1473-1484, 2010
|β-Amyloid burden in healthy aging: regional distribution and cognitive consequences|
KM Rodrigue, KM Kennedy, MD Devous, JR Rieck, AC Hebrank, ...
Neurology 78 (6), 387-395, 2012
|Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy|
ME Gurol, MC Irizarry, EE Smith, S Raju, R Diaz-Arrastia, T Bottiglieri, ...
Neurology 66 (1), 23-29, 2006
|Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein|
R Diaz-Arrastia, KKW Wang, L Papa, MD Sorani, JK Yue, AM Puccio, ...
Journal of neurotrauma 31 (1), 19-25, 2014
|The chronic and evolving neurological consequences of traumatic brain injury|
L Wilson, W Stewart, K Dams-O'Connor, R Diaz-Arrastia, L Horton, ...
The Lancet Neurology 16 (10), 813-825, 2017
|Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families|
C Cruchaga, S Chakraverty, K Mayo, FLM Vallania, RD Mitra, K Faber, ...
PloS one 7 (2), e31039, 2012
|Dementia resulting from traumatic brain injury: what is the pathology?|
S Shively, AI Scher, DP Perl, R Diaz-Arrastia
Archives of neurology 69 (10), 1245-1251, 2012
|Homocysteine and neurologic disease|
Archives of neurology 57 (10), 1422-1427, 2000
|Brain tissue oxygen monitoring and management in severe traumatic brain injury (BOOST-II): a phase II randomized trial|
DO Okonkwo, LA Shutter, C Moore, NR Temkin, AM Puccio, CJ Madden, ...
Critical care medicine 45 (11), 1907, 2017
|In vivo staging of regional amyloid deposition|
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
|A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly|
AJ Ho, JL Stein, X Hua, S Lee, DP Hibar, AD Leow, ID Dinov, AW Toga, ...
Proceedings of the National Academy of Sciences 107 (18), 8404-8409, 2010
|Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease|
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, L Minthon, ...
Neurology 85 (14), 1240-1249, 2015
|A serum protein–based algorithm for the detection of Alzheimer disease|
SE O’Bryant, G Xiao, R Barber, J Reisch, R Doody, T Fairchild, P Adams, ...
Archives of neurology 67 (9), 1077-1081, 2010
|Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup|
R Diaz-Arrastia, PM Kochanek, P Bergold, K Kenney, CE Marx, ...
Journal of neurotrauma 31 (2), 135-158, 2014
|Traumatic brain injury and risk of dementia in older veterans|
DE Barnes, A Kaup, KA Kirby, AL Byers, R Diaz-Arrastia, K Yaffe
Neurology 83 (4), 312-319, 2014